Traditional Chinese medicine for the adverse reaction of digestive system caused by highly active antiretroviral therapies (HARRT): a randomized control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001254

Enrollment

Unknown

Registered

2011-03-16

Start date

2009-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

A:Basic treatment

B:Basic treatment+TCM

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. HIV antibody test: Postive; 2. Patients with adverse reactin in digestive system caused by HARRT which is in accordance with the standard from National anti-virus treatment handbook for AIDS (2nd edition); 3. aged 18 to 65 years old; 4. Patients did not receive medicine that interfere the observation of this trial; 5. Patients voluntarily signed the informed consent; 6. Patients without digestive symptom 1 month before receiving HARRT.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, brain, kidney, hematology or endocrine system disease; 2. Patients with history of GI disease; 3. Patients with psychological disease including severe hysteria; 4. Patients with abnormal hepatic function (ALT>5 times of UL; 5. Pregnant or lactating women, or women who have birth plan; 6. Patients participated in other clinical trial; 7. Patients with any other disease or history that could confound the results or increase risk; 8. Pregnant or lactating women, or women who have birth plan.

Design outcomes

Primary

Measure	Time frame
Symptoms improvement;	—

Secondary

Measure	Time frame
Quality of Life;	—

Countries

China

Contacts

Public ContactYu Mao

myqmz58@yahoo.com+86 13552484984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026